High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia

Splenectomy increase the risk of severe and fatal infections, however the risk of Plasmodium vivax malaria is unknown. We quantified the Plasmodium species-specific risks of malaria and other outcomes following splenectomy in patients attending a hospital in Papua, Indonesia.Records of all patients...

Full description

Bibliographic Details
Main Authors:	Kho, S, Andries, B, Poespoprodjo, JR, Commons, RJ, Shanti, PAI, Kenangalem, E, Douglas, NM, Simpson, JA, Sugiarto, P, Anstey, NM, Price, RN
Format:	Journal article
Language:	English
Published:	Oxford University Press 2018

Similar Items

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
by: Thriemer, K, et al.
Published: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Setyadi, A, et al.
Published: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
by: Douglas, NM, et al.
Published: (2017)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, E, et al.
Published: (2017)

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study
by: Kho, S, et al.
Published: (2021)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
by: Douglas, NM, et al.
Published: (2020)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
by: Dini, S, et al.
Published: (2020)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
by: Douglas, N, et al.
Published: (2014)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
by: Commons, RJ, et al.
Published: (2018)

Early and late mortality after malaria in young children in Papua, Indonesia
by: Patriani, D, et al.
Published: (2019)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
by: Price, RN, et al.
Published: (2018)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
by: Rahmalia, A, et al.
Published: (2019)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
by: Lampah, D, et al.
Published: (2011)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
by: Price, R, et al.
Published: (2007)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a rising burden of Plasmodium vivax malaria
by: Poespoprodjo, JR, et al.
Published: (2019)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
by: Leonardo, L, et al.
Published: (2022)

Estimating the proportion of plasmodium vivax recurrences caused by relapse: A systematic review and meta-analysis
by: Commons, RJ, et al.
Published: (2020)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
by: Karyana, M, et al.
Published: (2008)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
by: Pava, Z, et al.
Published: (2020)

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
by: Anstey, N, et al.
Published: (2012)

Plasmodium vivax in the era of the shrinking P. falciparum map
by: Price, RN, et al.
Published: (2020)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
by: Oyong, DA, et al.
Published: (2018)

The anaemia of Plasmodium vivax malaria.
by: Douglas, N, et al.
Published: (2012)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
by: Devine, A, et al.
Published: (2017)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
by: Rahmalia, A, et al.
Published: (2023)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
by: Poespoprodjo, JR, et al.
Published: (2018)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.
by: Douglas, N, et al.
Published: (2013)

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.
by: Douglas, N, et al.
Published: (2013)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
by: Kenangalem, E, et al.
Published: (2019)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
by: Yilma, D, et al.
Published: (2023)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
by: Lampah, D, et al.
Published: (2015)

Circulating neutrophil extracellular traps and neutrophil activation are increased in proportion to disease severity in human malaria
by: Kho, S, et al.
Published: (2018)